[ad_1] Moderna Inc.’s stock soared 10% Tuesday to lead S&P 500 index gainers, after Oppenheimer upgraded the stock to the…
Browsing: vaccines
[ad_1] Anglo-Swedish drugmaker AstraZeneca on Thursday upped its earnings forecasts for the year as surging sales of cancer medicines offset…
[ad_1] BioNTech SE’s stock rose 2.5% early Monday after the company posted a surprise profit for the third quarter and…
[ad_1] The Nasdaq Composite Index is in the midst of a correction. A close look at its Nasdaq-100 subset shows…
[ad_1] Novavax NVAX, +5.24% stands out as a stark reminder of the biotech sector’s faltering steps in 2023. Once renowned…
[ad_1] Pfizer Inc. PFE, -1.73% said Friday that the U.S. Food and Drug Administration has approved the first five-in-one vaccine…
[ad_1] Shares of Pfizer Inc. and other biotech drug makers fell in the extended session Friday after Pfizer slashed $9…
[ad_1] Moderna Inc. announced positive interim results from a Phase 1/2 trial of its combination vaccine against COVID-19 and flu…
[ad_1] The Centers for Disease Control and Prevention on Friday recommended pregnant people get Pfizer Inc.’s PFE, -0.49% maternal vaccine…
[ad_1] It may be time to get your COVID-19 vaccine again. There’s a new booster that’s coming out to guard…